DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Even though nuclear abnormalities have been described in the dystroglycanopathies [37], the significance and peptide nature of the nuclear localisation of dystroglycan in skeletal muscle tissue has remained elusive.